# Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)

> **NCT03831906** · NA · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 2570 (actual)

## Conditions studied

- Tuberculosis
- Severe Pneumonia
- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Xpert MTB/RIF Ultra (Ultra)

## Key facts

- **NCT ID:** NCT03831906
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-20
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 2570 (ACTUAL)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831906, "Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03831906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*